A Case of Antithyroid Drug-Induced Agranulocytosis Treated with Granulocyte Colony-Stimulating Factor (G-CSF) and Methylprednisolone / 대한소아내분비학회지
Journal of Korean Society of Pediatric Endocrinology
;
: 81-85, 2004.
Article
in Korean
| WPRIM
| ID: wpr-153301
ABSTRACT
Although rare, agranulocytosis is the most serious, potentially fatal side effect of antithyroid drug. We experienced a 13-year-old girl who developed methimazole-induced agranulocytosis at 1 month after the initiation of treatment. Her granulocyte count recovered after discontinuation of methimazole and treatment with broad spectrum-antibiotics, G-CSF, and methylprednisolone. After recovery from agranulocytosis she was treated with radioiodine ablation therapy. Early detection and proper management of antithyroid drug-induced agranulocytosis is very important.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Methylprednisolone
/
Granulocyte Colony-Stimulating Factor
/
Agranulocytosis
/
Granulocytes
/
Methimazole
Type of study:
Screening study
Limits:
Adolescent
/
Female
/
Humans
Language:
Korean
Journal:
Journal of Korean Society of Pediatric Endocrinology
Year:
2004
Type:
Article
Similar
MEDLINE
...
LILACS
LIS